GTR Home > Tests > Search results - C1836482[DISCUI]

Apply filters

Showing tests for all 1747 conditions

Compare labs

Your search term can be found in tests with a total of 1747 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1836482[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 33 tests for 1747 conditions in 13 labs

CCentoBreast (hereditary breast cancer) panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (13)

CLi-Fraumeni syndrome type 2

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTier 1: Hereditary Lymphoma Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (8)

CColorectal Cancer NextGen Sequencing (NGS) And Deletion/Duplication Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (21)
Total targets (17)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CFocus Cancer Panel - 40 Genes

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (56)
Total targets (40)

CInvitae Prostate Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (15)
Total targets (12)

CInvitae Thyroid Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (32)
Total targets (11)

CInvitae Multi-Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (139)
Total targets (79)

CInvitae Common Hereditary Cancers Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (76)
Total targets (42)

CLi-Fraumeni syndrome type 2 (sequence analysis of CHEK2 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CLi-Fraumeni syndrome (deletions/duplication on CHEK2 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • D Deletion/duplication analysis

CColon Cancer Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (12)
Total targets (19)

CBreast Cancer – Basic Diagnostics

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (11)

CBreast Cancer

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (37)

CHereditary Cancer Syndromes, Comprehensive Diagnostics

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (94)

CPolyposis Coli

Total conditions (7)
Total targets (7)

COvarian Cancer – Basic Diagnostics

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (13)

COvarian Cancer

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (27)

CInvitae Breast Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (22)
Total targets (26)

Showing 1 to 20 of 33 tests for 1747 conditions in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.